The Human Microbiome is a Source of Therapeutic Drug Targets
Symberix Co-Founder Matthew Redinbo and Senior Scientist Bret Wallace review the roles that symbiotic bacteria play in the chemistry of human health, with a focus on the emerging appreciation that specific enzyme targets can be selectively disrupted to achieve clinical outcomes.
Symberix, Inc. 4819 Emperor Blvd, #400 Durham, NC 27703
Icons by icons8 .